Bavarian Nordic A/S (CPH:BAVA)
Denmark · Delayed Price · Currency is DKK 183.30
-2.95 (-1.58%)
At close: Mar 19, 2026
Bavarian Nordic Market Cap
Bavarian Nordic has a market cap or net worth of 14.43 billion as of March 19, 2026. Its market cap has increased by 10.27% in one year.
Market Cap
14.43B
Enterprise Value
11.22B
Revenue
6.24B
Ranking
n/a
PE Ratio
10.58
Stock Price
183.30
Market Cap Chart
Since November 5, 1998, Bavarian Nordic's market cap has increased from 42.71M to 14.43B, an increase of 33,679.28%. That is a compound annual growth rate of 23.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 18, 2026 | 14.43B | -3.41% |
| Dec 30, 2025 | 14.94B | 0.41% |
| Dec 30, 2024 | 14.88B | 7.57% |
| Dec 29, 2023 | 13.83B | -8.19% |
| Dec 30, 2022 | 15.06B | -20.32% |
| Dec 30, 2021 | 18.90B | 73.28% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.11T |
| Genmab | 105.16B |
| Coloplast | 100.45B |
| ALK-Abelló | 46.53B |
| H. Lundbeck | 36.84B |
| Zealand Pharma | 19.81B |
| Ambu A/S | 18.81B |
| GN Store Nord | 15.32B |